Oaktree Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
California Resources
CRC
|
+$104M |
| 2 |
TLN
Talen Energy Corp
TLN
|
+$98.2M |
| 3 |
Indivior Pharmaceuticals
INDV
|
+$58.9M |
| 4 |
Liberty Global Class A
LBTYA
|
+$41.9M |
| 5 |
Infosys
INFY
|
+$37.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TORM
TRMD
|
+$129M |
| 2 |
Banco Bradesco
BBD
|
+$53M |
| 3 |
Star Bulk Carriers
SBLK
|
+$50M |
| 4 |
Vale
VALE
|
+$48.8M |
| 5 |
JD.com
JD
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 41.65% |
| 2 | Consumer Discretionary | 10.06% |
| 3 | Materials | 8.12% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 4.11% |
Similar funds
Oaktree Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Oaktree Capital Management held 174 positions worth $6.24B, down 0.9% from $6.3B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Oaktree Capital Management withdrew a net $584M in Q3 2024, closing 6 positions and reducing 12 holdings. Its most notable exit was Gerdau, an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Energy at 42% of assets, down from 45% a quarter earlier, followed by Consumer Discretionary and Materials.
Against the trend, Oaktree Capital Management opened a new position in California Resources worth $107M.
- Oaktree Capital Management's largest Q3 2024 buy was California Resources: 2,046,753 shares worth $107M.
- Oaktree Capital Management added most to Indivior Pharmaceuticals in Q3 2024, an estimated $58.9M increase.
- Oaktree Capital Management's biggest Q3 2024 reduction was TORM, cutting an estimated $129M.
- Oaktree Capital Management fully exited Gerdau in Q3 2024, selling an estimated $19.4M.
- Oaktree Capital Management's ten largest holdings make up 56% of its $6.24B portfolio in Q3 2024.
- Oaktree Capital Management opened 11 new positions and closed 6 in Q3 2024.
- Oaktree Capital Management's portfolio value fell 0.9% quarter-over-quarter to $6.24B.
Based on Oaktree Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.